SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending due to regulatory clarity for ANKTIVA's resubmission for papillary bladder cancer, requiring no new clinical trials, coupled with expanding international approvals. The community is actively discussing the potential for a significant short squeeze, driven by high short interest and exceptional volume, as many investors embrace the long-term "cancer cure" narrative. This optimism persists even as the broader market faces headwinds, highlighting IBRX's standout performance and promising pipeline.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following its announcement of a record date for a digital token initiative, drawing significant community discussion around its venture into crypto. This attention is amplified by escalating geopolitical rhetoric, including commentary on Greenland and new tariff threats, which is heavily influencing market sentiment and broader economic concerns. The stock continues to be a focal point for politically charged narratives, with both enthusiastic supporters and market participants expressing strong, polarized views.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

Top Wealth Group Holding is trending due to its recent announcement to acquire a luxury wine authentication and trading business, diversifying its offerings beyond caviar. However, a public offering at $7.00 per unit has led to significant price volatility and a sharp decline, sparking strong community debate about whether the move signals a legitimate long-term strategy or a "pump and dump" scenario. Investors are actively discussing the immediate impact of the offering and the company's valuation amidst these developments.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to highly positive Phase 1 clinical trial results for its oral drug, soquelitinib, in treating moderate to severe atopic dermatitis, particularly in patients resistant to other therapies. The outstanding efficacy and safety profile from this early data are generating significant community excitement, with many anticipating blockbuster potential and a paradigm shift for inflammation and immunology, while some caution about the trial's small size and potential for a future stock offering.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing an unprecedented surge driven by escalating AI demand for memory chips, leading to a global supply shortage. This momentum is reinforced by significant capacity expansion initiatives, including a Taiwan fab acquisition and a New York megafab groundbreaking, alongside notable insider buying and analyst upgrades. While many celebrate its "monster" rally and market-leading strength, a segment of the community remains cautious, labeling it an "overextended" "bubble stock" due for a pullback.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending following its acquisition of Texas Critical Data Centers and a new partnership to co-develop a large-scale AI data center campus in West Texas. The community is actively discussing an anticipated hyperscaler tenant announcement, which many believe could significantly boost the stock. Despite some lingering concerns over past allegations, investors are keenly focused on the company's strategic advancements in the high-demand AI infrastructure sector.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending as the community eagerly discusses its strategic expansion plans, including a new rare earth facility in France backed by government support, alongside advancements at its Stillwater magnet plant. These developments are viewed within the broader context of increasing geopolitical tensions and a global push for rare earth independence from traditional suppliers, though some express frustration over consistent price resistance and perceived manipulation compared to sector peers.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following a significant non-exclusive licensing deal with Pfizer for its Matrix-M adjuvant, a move widely seen as powerful validation for the platform technology beyond its initial COVID application. The community is actively debating whether this partnership signals NVAX's evolution into a royalty-generating company and if high short interest will trigger a substantial upward move, despite some expressing frustration over the immediate market reaction amidst a broader downturn.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is gaining significant traction following key innovation awards and its confirmed partnership with Celestial AI, recently acquired by Marvell, igniting optimism for upcoming major customer announcements. The community is actively discussing strong market momentum and a potential gamma squeeze, highlighting the company's unique optical interposer technology as a critical enabler for AI and data center infrastructure.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is a major talking point as geopolitical tensions escalate over the US's pursuit of Greenland and potential tariffs, prompting a Danish pension fund to divest from US Treasuries citing credit risk concerns. The community remains sharply divided, with some fearing broader international divestment and higher yields while others anticipate eventual rate cuts amid a slowing economy and increased Fed intervention.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Conduit Pharmaceuticals Inc. (CDT) tumbled 17% on Wednesday after the company announced that it has entered into a development agreement with privately held animal health company Manoira Corporation.As part of the <a target="_blank" rel="noopener noreferrer nofollow" href="https://s3.amazonaws.com/b2icontent.irpass.cc/2892/rl146071.pdf">agreement</a>, Manoira will evaluate Conduit's clinical-stage candidates AZD1656 and AZD5658 in animal health indications.Manoira will initially focus on the evaluation of AZD1656 in animal Osteoarthritis. Osteoarthritis is a degenerative joint condition in companion animals.The collaboration will help Conduit accelerate its understanding of AZD1656's mechanism of action, safety profile, and potential efficacy across species, while retaining ownership of all data and intellectual property generated for human applications.The partnership, Conduit said, opens potential new revenue streams in the high-growth veterinary market.The parties will determine any future financial benefits and implications upon review of the results of the evaluations and how to proceed as a result of any such findings, Conduit said.Manoira has agreed to fund all the developmental activities of the collaboration, and Conduit has agreed to issue Manoira an up-front consideration of $500,000. Conduit’s consideration will be settled through the issuance of 154,799 shares of common stock at $3.23, or its closing price on Tuesday.On Stocktwits, retail sentiment around CDT stayed unmoved within the ‘extremely bullish’ territory over the past 24 hours while message volume remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:1264/128;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_04_at_11_58_35_AM_png_7bfe8d0833.webp" alt="CDT's Sentiment Meter and Message Volume as of 12:00 p.m. ET on June 4, 2025 | Source: Stocktwits" width="1264" height="128"><figcaption>CDT's Sentiment Meter and Message Volume as of 12:00 p.m. ET on June 4, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user said that they bought the stock during the dip.<stembedurl>https://stocktwits.com/BankingBig/message/616778690</stembedurl>Another sees it rising back to over $10.<stembedurl>https://stocktwits.com/LetsgoDudeszi/message/616768852</stembedurl><a href="https://stocktwits.com/symbol/CDT">CDT stock</a> is down by approximately 98% this year and has lost most of its value over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/lucid-inks-deal-with-graphiteone/chkuKwsRbwU">Lucid Inks Deal With Graphite One To Strengthen Local Graphite Supply Chain: Retail Sees Stock Hitting $3 To $5 In Coming Months</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10

Manoira will initially focus on the evaluation of AZD1656 in animal Osteoarthritis.

Equity

Shares of Conduit Pharmaceuticals Inc. (CDT) dropped 5% on Friday morning after the company’s board <a target="_blank" rel="noopener noreferrer nofollow" href="https://s3.amazonaws.com/b2icontent.irpass.cc/2892/rl145666.pdf">approved</a> a 1-for-15 reverse stock split of its common stock.Earlier, shareholders approved the stock split proposal in a meeting on May 5, leaving it upon the board to determine the exact split ratio.The company said the reverse stock split will become effective on May 19 at 5:00 p.m. ET, and the stock will start trading on a reverse stock-split adjusted basis at market open on May 20.On May 19 evening, every 15 shares of the firm’s issued and outstanding common stock will be combined into one share, reducing the number of outstanding shares of common stock to about 755,900.The company said no fractional shares will be issued in connection with the split, and those entitled to a fractional share will instead receive a proportional cash payment.Earlier this month, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://s3.amazonaws.com/sec.irpass.cc/2892/0001641172-25-010405.htm">flagged</a> doubts regarding its ability to continue as a going concern for at least the next 12 months.It said management has determined it does not have sufficient cash and other sources of liquidity to fund its current business plan, adding that it had cash and cash equivalents of only $2.1 million as of the end of the first quarter.On Stocktwits, retail sentiment around Conduit Pharmaceuticals remained unmoved within the ‘bearish’ territory over the past 24 hours while message volume remained at ‘extremely low’ levels.<figure class="image"><img style="aspect-ratio:625/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_16_at_10_29_21_AM_png_0ccaac1374.webp" alt="CDT's Sentiment Meter and Message Volume as of 10:30 a.m. ET on May 16, 2025 | Source: Stocktwits" width="625" height="61"><figcaption>CDT's Sentiment Meter and Message Volume as of 10:30 a.m. ET on May 16, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user, however, expressed skepticism about the stock’s performance.<stembedurl>https://stocktwits.com/rkfrkf/message/614872963</stembedurl>The shares closed at over $1 last in early April.<a href="https://stocktwits.com/symbol/CDT">CDT stock</a> is down 95% this year and has lost nearly all of its value over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/trump-says-tariff-deals-with-other-countries-in-two-three-weeks/chiwIazRbnt">Trump Says Tariff Deals With Other Nations To Be Set Within 2 To 3 Weeks: ‘I Think We’re Going To Be Very Fair’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic

The company said that the reverse stock split will become effective on May 19 at 5:00 p.m. ET, and the stock will start trading on a reverse stock-split adjusted basis at market open on May 20. 

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic 

The company said that the reverse stock split will become effective on May 19 at 5:00 p.m. ET, and the stock will start trading on a reverse stock-split adjusted basis at market open on May 20. 


CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

Current Price	$1.35
Prev Close	$1.42
Open	$1.49
Dividend Yield	0.00%
50-Day Moving Average	$1.78
Beta	0.84
Avg. Volume	209,634.23
PE Ratio	0.00

52-Week High	$876.00
52-Week Low	$1.24
Market Capitalization	$2.31M
EPS (Annual)	-$2,463.72
Price to Book	0.42
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

CDT
Conduit Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CDT News

CDTConduit Pharmaceuticals Inc